Identification of a Novel Antagonist of BRS-3 from Natural Products and Its Protective Effects Against H2O2-Induced Cardiomyocyte Injury
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062745 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jihong Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, Chi…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Hydrogen Peroxide, Biological Products, Protective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, the Key Scientific Project of Shanghai Jiao Tong University.
Abstract (Originalsprache)
The identification of exogenous ligands from natural products is an alternative strategy to explore the unrevealed physiological functions of orphan G-protein-coupled receptors (GPCRs). In this study, we have successfully identified and pharmacologically characterized licoisoflavone A (LIA) as a novel selective antagonist of BRS-3, an orphan GPCR. Functional studies showed that pretreatment with LIA ameliorated hydrogen peroxide (H2O2)-induced cardiomyocyte injury. Furthermore, LIA pretreatment significantly restored the activities of malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT), as well as lactate dehydrogenase (LDH) levels, in H9c2 cells following H2O2 exposure. The protective effect of LIA was also evident in primary cardiomyocytes from rats and mice against H2O2-induced cell injury but was absent in primary cardiomyocytes derived from bombesin receptor subtype-3 knockout (Brs3−/y) mice, strongly confirming the mechanism of LIA’s action through BRS-3 antagonism. Proteomics studies further revealed that LIA exerted its protective effects via activating the integrin/ILK/AKT and ERK/MAPK signaling pathways. Complementary findings from Bantag-1, a well-recognized antagonist of BRS-3, in human embryonic kidney 293 mBRS-3 (HEK293-mBRS-3) stable cells and B16 cell lines, which demonstrated resistance to H2O2-induced damage, further supported the pivotal role of BRS-3 in oxidative stress-induced cell injury. Our study contributes to expanding our understanding of the potential pharmacological functions of BRS-3, unveiling previously unknown pharmacological functionality of this orphan receptor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
- State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
- Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
- Zhiyuan College, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Lehao Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- the Key Scientific Project of Shanghai Jiao Tong University
- Key Scientific Project of Shanghai Jiao Tong University
Zitieren
APA
Lu, J., Wu, L., Zhu, J., Zhou, H., Fang, M., Liang, H., Guo, M., Chen, M., Zhu, Y., Wang, J., Xiao, H., & Zhang, Y. (2025). Identification of a Novel Antagonist of BRS-3 from Natural Products and Its Protective Effects Against H2O2-Induced Cardiomyocyte Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062745
Vancouver
Lu J, Wu L, Zhu J, Zhou H, Fang M, Liang H, et al. Identification of a Novel Antagonist of BRS-3 from Natural Products and Its Protective Effects Against H2O2-Induced Cardiomyocyte Injury. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062745
BibTeX
@article{Lu2025,
author = {Lu, Jihong and Wu, Lehao and Zhu, Jianzheng and Zhou, Han and Fang, Mingzhu and Liang, Hongshuo and Guo, Miao and Chen, Mo and Zhu, Yuhang and Wang, Jixia and Xiao, Hua and Zhang, Yan},
title = {Identification of a Novel Antagonist of BRS-3 from Natural Products and Its Protective Effects Against H2O2-Induced Cardiomyocyte Injury},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062745}
}
EUVIMED